TrialJournal of neuro-oncology2011
Phase II study of sunitinib malate in patients with recurrent high-grade glioma.
B Neyns et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
77 papers cite itlatest 60 shown
this paperpooled ittrialcites it